Grant Thornton International and Kingland Celebrate 20 Years of Partnership
For 20 years, Grant Thornton member firms around the world have relied on Kingland's financial interest tracking solution to continuously monitor for restricted financial interests that professionals might hold. Today, that capability is further strengthened through direct integration with brokerage firms, enabling professionals' financial interest disclosure to be done automatically.
"We are proud of our long-standing partnership with Grant Thornton International and the trust they place in our solutions for their critical global processes," said
For more information about Kingland's solutions, visit: Public Accounting | Kingland
About Kingland
Kingland is a leading provider of regulatory-grade software solutions, supporting global financial institutions, exchanges, accounting firms and other highly regulated entities with critical transformation processes. Since 1992, Kingland has helped data-intensive, highly regulated clients discover new ways to grow securely and protect their reputation. For more information, please visit www.kingland.com.
About Grant Thornton International Ltd
Grant Thornton International Ltd is the international coordinating entity for one of the world's leading networks of independent professional services firms. Grant Thornton member firms operate in over 150 markets with a shared commitment to quality, integrity and client service. For more information, visit www.grantthornton.global.
View original content:https://www.prnewswire.com/news-releases/grant-thornton-international-and-kingland-celebrate-20-years-of-partnership-302728692.html
SOURCE Kingland
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Insurance Agent Nick Hogan Explains What First-Time Homeowners Often Miss About Homeowners Insurance in HelloNation
- Phase III TAISHAN-302 Trial Shows Tam-Peli Significantly Improves Survival in Relapsed Small-Cell Lung Cancer
- Sacituzumab Govitecan Plus Pembrolizumab Does Not Meet Primary Endpoints in First-Line PD-L1-High Metastatic NSCLC
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share